Hospital
East Carroll Parish Hospital
East Carroll Parish Hospital was paid $5.76M by Medicaid between Jan 2018 and Dec 2024, across 117 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoEAST CARROLL PARISH HOSPITAL
LAKE PROVIDENCE, LA 71254
LAKE PROVIDENCE, LA 71254
33aNPI1982695441assigned 11/03/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.76M
24GClaims78,313
24DCodes billed117
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#45 of 96
Median peer was paid$5.17M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,028 | $489K | |
| 2019 | 11,643 | $649K | |
| 2020 | 4,946 | $375K | |
| 2021 | 8,509 | $728K | |
| 2022 | 10,648 | $1.18M | |
| 2023 | 16,970 | $1.46M | |
| 2024incomplete | 12,569 | $882K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 13,156 | 6,359 | $1.34M |
| 0223U | 16% | 2,697 | 2,481 | $897K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 4,912 | 2,368 | $777K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 11% | 2,792 | 1,884 | $629K |
| A0425 | Ground mileage, per statute mile | 8.9% | 3,159 | 2,069 | $514K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 4.0% | 572 | 557 | $232K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.4% | 5,778 | 5,358 | $198K |
| 80050 | General health panel | 3.3% | 4,710 | 4,248 | $193K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 1,699 | 1,551 | $140K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 2,706 | 1,922 | $136K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 1.3% | 140 | 73 | $77K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,242 | 1,113 | $43K |
105 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 412 | $35K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 487 | $35K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 82 | $31K |
| G0378 | Hospital observation service, per hour | <1% | 176 | $30K |
| 80053 | Comprehensive metabolic panel | <1% | 3,057 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,479 | $29K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 242 | $28K |
| 99285 | Emergency room visit (most serious) | <1% | 101 | $26K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 26 | $24K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 140 | $23K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 179 | $22K |
| 71045 | Radiologic examination, chest; single view | <1% | 246 | $17K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 2,031 | $17K |
| 80061 | Lipid panel | <1% | 1,401 | $17K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 454 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 455 | $16K |
| 99221 | <1% | 715 | $16K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 174 | $12K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 145 | $12K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 729 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 497 | $8K |
| 83721 | <1% | 1,440 | $8K | |
| 83655 | <1% | 568 | $7K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 50 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 955 | $7K |
| 83880 | <1% | 254 | $7K | |
| 99218 | <1% | 293 | $6K | |
| 80047 | <1% | 752 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 113 | $6K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 210 | $6K |
| 0001A | <1% | 330 | $6K | |
| 0002A | <1% | 280 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 84 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 496 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 141 | $5K |
| J3490 | Unclassified drugs | <1% | 411 | $5K |
| 83735 | <1% | 1,017 | $5K | |
| 99224 | <1% | 503 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 794 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,393 | $4K |
| 84484 | <1% | 370 | $3K | |
| 0003A | <1% | 70 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 51 | $2K |
| 82553 | <1% | 388 | $2K | |
| 94761 | <1% | 730 | $2K | |
| 82150 | <1% | 334 | $2K | |
| 84481 | <1% | 129 | $1K | |
| 82550 | <1% | 359 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 60 | $1K |
| 84439 | <1% | 129 | $1K | |
| 81001 | <1% | 822 | $950.76 | |
| 80305 | <1% | 96 | $945.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 17 | $657.83 |
| 86701 | <1% | 58 | $506.73 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 456 | $498.38 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 36 | $496.73 |
| 85651 | <1% | 116 | $444.60 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 41 | $364.55 |
| 80335 | <1% | 14 | $266.00 | |
| 80369 | <1% | 14 | $260.54 | |
| 80372 | <1% | 14 | $252.56 | |
| 80373 | <1% | 14 | $252.56 | |
| 80332 | <1% | 14 | $245.07 | |
| 80366 | <1% | 14 | $245.07 | |
| 80323 | <1% | 14 | $245.07 | |
| 80338 | <1% | 14 | $245.07 | |
| 80368 | <1% | 14 | $245.07 | |
| 80357 | <1% | 14 | $245.07 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 28 | $219.83 |
| 80320 | <1% | 14 | $178.22 | |
| 80355 | <1% | 14 | $175.14 | |
| 80321 | <1% | 14 | $159.74 | |
| 83992 | <1% | 14 | $140.00 | |
| 80346 | <1% | 14 | $129.50 | |
| 91300 | <1% | 547 | $124.16 | |
| 80354 | <1% | 14 | $119.00 | |
| 80356 | <1% | 14 | $119.00 | |
| 80348 | <1% | 14 | $119.00 | |
| 80365 | <1% | 14 | $119.00 | |
| 80362 | <1% | 14 | $119.00 | |
| 80361 | <1% | 14 | $119.00 | |
| 80360 | <1% | 14 | $115.50 | |
| 80350 | <1% | 14 | $115.50 | |
| 80371 | <1% | 14 | $115.50 | |
| 80349 | <1% | 14 | $115.50 | |
| 80358 | <1% | 14 | $113.82 | |
| 80359 | <1% | 14 | $108.50 | |
| 80324 | <1% | 14 | $108.36 | |
| 80353 | <1% | 14 | $105.56 | |
| 82948 | <1% | 40 | $97.28 | |
| 80345 | <1% | 14 | $79.87 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $65.48 |
| 82044 | <1% | 15 | $47.48 | |
| 81003 | <1% | 22 | $2.24 | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 857 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 81 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 16 | $0.00 |
| 81025 | 0% | 12 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 14 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 259 | $0.00 |
| 00000 | 0% | 704 | $0.00 | |
| 3008F | 0% | 30 | $0.00 | |
| A0999 | Unlisted ambulance service | 0% | 40 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 37 | $0.00 |
| A0398 | Als routine disposable supplies | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialENGLERTH, LADONNA (ADMINISTRATOR, CEO)
| Provider | Location | Paid |
|---|---|---|
| East Carroll Parish Hospital | Lake Providence, LA | $244K |
| East Carroll Ambulance Service | Lake Providence, LA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.